STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION Prior to the IPO, the Company granted options to purchase shares of the Company’s common stock and restricted stock units (“RSU”) in respect of shares of the Company’s common stock to employees, directors and consultants under the Company’s 2011 Equity Incentive Plan. In July 2021, Duolingo adopted the 2021 Incentive Award Plan (“2021 Plan”) and the 2021 Employee Stock Purchase Plan (“ESPP”), each of which became effective on July 26, 2021 in connection with the IPO. An aggregate of 7,946 shares and 1,119 shares of Class A common stock were made available for future issuance under the 2021 Plan and ESPP, respectively. On each January 1, the number of shares of the Company’s Class A common stock available for issuance under the 2021 Plan have been, and through January 1, 2031, will be, increased by the lesser of (i) 5% of the shares outstanding on the preceding December 31 (calculated on an as-converted basis) and (B) such smaller number of shares of common stock as determined by the Board or the Committee (as defined in the 2021 Plan). On January 1, 2023, the 2021 Plan and ESPP were increased by 2,018 shares and 319 shares, respectively. The Company’s stock options vest based on terms in the stock option agreements, which generally provide for vesting over four years based on continued service to the Company and its subsidiaries. Each option has a term of ten years. Stock options granted under the 2021 Plan must generally have an exercise price of not less than the estimated fair market value of the underlying Class A common stock at the date of the grant. No options have been granted under the 2021 Plan. A summary of stock option activity under the Plans was as follows: Number of Weighted- Weighted- average remaining contractual life (years) Aggregate intrinsic value Options outstanding at January 1, 2023 4,410 $ 14.04 6.25 $ 251,832 Granted (1) — Exercised (542) 8.57 Forfeited and expired (3) 22.37 Options outstanding at March 31, 2023 3,865 $ 14.80 6.17 $ 493,610 Options exercisable at March 31, 2023 3,297 $ 14.05 6.00 $ 423,829 ________________ (1) There were no stock options granted during the three months ended March 31, 2023 and 2022. The total intrinsic value of options exercised was approximately $55,062 and $60,334 for the periods ended March 31, 2023 and 2022, respectively. A summary of RSU activity under the Plans was as follows: Restricted stock units Weighted- Outstanding at January 1, 2023 2,036 $ 85.74 Granted 185 97.62 Released (115) 84.18 Forfeited (58) 97.80 Outstanding at March 31, 2023 2,048 $ 86.56 As of March 31, 2023, there was approximately $4,522 of unrecognized compensation cost related to stock options granted under the plans with a weighted-average period of approximately one year. The amount of unrecognized compensation expense for RSUs as of March 31, 2023 was $163,373 with a weighted-average period of approximately three years, for a total unrecognized compensation expense of $167,895. There were 10,011 shares available for grant at March 31, 2023. Performance-based RSUs In June 2021, the Company granted an aggregate of 1,800 performance-based RSUs (the “Founder Awards”) to the Company’s founders. The Founder Awards vest upon the satisfaction of both a service-based condition and a performance-based condition and generally are settled one year after vesting. The service-based condition is satisfied as to 25% of the Founder Awards on each anniversary of the completion of the IPO, subject to the continuous service of the founders through the applicable date. The performance-based condition will be satisfied with respect to each of 10 equal tranches only if the trailing 60-calendar day volume-weighted-average closing trading price of the Company’s Class A common stock reaches certain stock-price hurdles for each such tranche, as set forth below, over a period of 10 years from the date of grant. Any RSUs associated with stock-prices hurdle not achieved by the tenth anniversary of the date of grant will terminate and be canceled for no additional consideration to the founders. The stock-price hurdles and number of RSUs eligible to vest will be adjusted to reflect any stock splits, stock dividends, combinations, reorganizations, reclassifications, or similar events under the 2021 Plan. The Founder Awards will be settled in shares of the Company’s Class B common stock. Tranche Company Stock Price Hurdle Number of RSUs Eligible to Vest 1 $ 127.50 90 2 $ 153.00 90 3 $ 178.50 90 4 $ 204.00 180 5 $ 255.00 180 6 $ 306.00 180 7 $ 357.00 180 8 $ 408.00 180 9 $ 612.00 270 10 $ 816.00 360 The Company estimated the grant date fair value of the Founder Awards using a model based on multiple stock-price paths developed through the use of a Monte Carlo simulation that incorporates into the valuation the possibility that the stock-price hurdles may not be satisfied. The weighted-average grant date fair value of the Founder Awards was estimated to be $61.56 per share and the Company estimates that it will recognize total stock-based compensation expense of approximately $110,817 over the derived service period of each of the ten separate tranches which is between 3.58 – 5.92 years. If the stock-price hurdles are met sooner than the requisite service period, the stock-based compensation expense will be adjusted to prospectively recognize the remaining expense over the remaining derived service period. Provided that the founders continue to provide services to the Company, stock-based compensation expense is recognized over the derived service period, regardless of whether the stock-price hurdles are achieved. The stock-price hurdles for the first two tranches were met during 2021. No additional stock-price hurdles have been met since. The Company recognized $7,140 and $8,019 of stock-based compensation expense related to these awards for the three months ended March 31, 2023 and 2022, respectively, which is included within General and administrative in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. As of March 31, 2023, there is $56,217 of unrecognized compensation expense related to these awards. Total stock-based compensation expense was $21,073 and $14,586 for the three months ended March 31, 2023 and 2022, respectively. Stock based compensation expense is included in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss as shown in the following table: Three Months Ended March 31, 2023 2022 Cost of revenues $ 11 $ 6 Research and development 9,346 3,632 Sales and marketing 779 348 General and administrative 10,937 10,600 Total $ 21,073 $ 14,586 Nominal amounts of stock based compensation expense is capitalized into intangible assets for the three months ended March 31, 2023 and 2022. |